33 CALIFORNIE
Overview
33 CALIFORNIE is a Lyon-based investment firm led by Stéphane Legastelois, focusing on the healthcare sector, particularly biotechnology, medical devices, and e-health. The firm launched CaLySeed in November 2022 to provide seed capital to innovative startups in these fields. Since its inception in 2019, 33 CALIFORNIE has invested directly in 16 companies, with an average investment of €100,000, totaling €1.6 million. Additionally, it has supported eight other startups in the healthcare sector through indirect funding. The firm's investment strategy emphasizes early-stage support, offering both financial backing and strategic guidance to entrepreneurs, from initial proof of concept to their first fundraising efforts. This approach aims to foster innovation and growth within the healthcare industry in France.
Investment Focus
- Innovative healthcare startups
- Early-stage companies
- Biotech ventures
Portfolio Companies
Reach 33 CALIFORNIE directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about 33 CALIFORNIE
What sectors does 33 CALIFORNIE invest in?
33 CALIFORNIE invests in Healthcare, Medical Devices, Biotechnology, E-health and Nutraceuticals, and is based in France. 33 CALIFORNIE is listed as a private investment firm in the ConnectSafely investor database.
What stage does 33 CALIFORNIE invest at?
33 CALIFORNIE backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 100K - 1M.
Which regions does 33 CALIFORNIE invest in?
33 CALIFORNIE invests across France.
What companies has 33 CALIFORNIE invested in?
33 CALIFORNIE's portfolio includes MAG4HEALTH.
Last updated · Source: ConnectSafely investor database
